LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings Replaces time-consuming manual spot checking with continuous, near real-time active patient...

CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms

CU Medicine invents a non-invasive technology for people with uninvestigated bowel symptoms

HONG KONG, Dec. 4, 2024 /PRNewswire/ -- The Chinese University of Hong Kong's Faculty of Medicine (CU Medicine) has, for the first time, discovered novel microbial signatures associated with inflammation of the gastrointestinal (GI) tract and...

World's Largest Biometric System for Banks by DERMALOG Protects the Accounts of Over 64 Million Customers

World's Largest Biometric System for Banks by DERMALOG Protects the Accounts of Over 64 Million Customers

HAMBURG, Germany and LAGOS, Nigeria, Dec. 4, 2024 /PRNewswire/ -- Over 64 million Nigerians now conduct their banking transactions through accounts safeguarded by advanced biometric technology. This cutting-edge solution was developed by DERMALOG,...

Moon Creative Lab Venture Variloom™ Wins ISPO 2024 Award in Collaboration with Rip Curl

Moon Creative Lab Venture Variloom™ Wins ISPO 2024 Award in Collaboration with Rip Curl

Variloom 3DP Filament and Print System Recognized as Part of Rip Curl's Mirage3DP Boardshort Innovating in Sustainable and Functional Design and Materials MUNICH, Germany and PALO ALTO, Calif. and TOKYO, Dec. 3, 2024 /PRNewswire/ -- Moon Creative...

The total power installation in Aksu exceeded the 10 million kilowatt mark for the first time

The total power installation in Aksu exceeded the 10 million kilowatt mark for the first time

AKSU, China, Dec. 2, 2024 /PRNewswire/ -- Recently, the Aksu region has ushered in a historic moment for the development of new energy. With the successful implementation of the 1 million kilowatts of full-capacity grid-connected power generation in...

Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation

Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation

BAKU, Azerbaijan, Nov. 29, 2024 /PRNewswire/ -- A news report by Huanqiu.com: Guangdong Mentech Technology Co., Ltd. (hereafter referred to as "Mentech") participated in COP29 in Baku, Azerbaijan, to discuss low-carbon solutions and contribute to...

Xinjiang applies drone energized flushing and distribution line insulators in desert for the first time

Xinjiang applies drone energized flushing and distribution line insulators in desert for the first time

URUMQI, China, Nov. 29, 2024 /PRNewswire/ -- On November 29, State Grid Xinjiang Electric Power Co., Ltd. successfully completed the energized flushing of UAV distribution line insulators in the desert area in Kashgar, marking Xinjiang's major...

Hankyung.com introduces: JMsys, Development of an outdoor app that provides voice guidance even on mountain trails

Hankyung.com introduces: JMsys, Development of an outdoor app that provides voice guidance even on mountain trails

SEOUL, South Korea, Nov. 28, 2024 /PRNewswire/ -- JMsys is a company that developed the industry's first blockchain-based mountain trail voice guidance platform. It has been recognized for its technological prowess by the Ministry of Science and ICT...

ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability

ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability

SINGAPORE, Nov. 28, 2024 /PRNewswire/ -- The 7th edition of Industrial Transformation ASIA-PACIFIC (ITAP) - a HANNOVER MESSE event, organised by Constellar with international partner Deutsche Messe, was held from 14-16 October 2024 at Singapore...

GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment

GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment

YONGIN, South Korea, Nov. 26, 2024 /PRNewswire/ -- GC Biopharma and Novel Pharma today announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new drug for Sanfillippo syndrome type A...

  • 1
  • 2
  • 3
  • 4
  • menu
    menu